Clinical Trials on Urological Diseases

Total 379683 results

NephroNet, Inc.
Mallinckrodt

Active, not recruiting

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients (FACT)

Fibrillary Glomerulonephritis

United States
Astellas Pharma Europe B.V.

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder (SYNERGY II)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

Belgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury

Hypertension | Proteinuria | Drug-Induced Nephropathy

United States
Astellas Pharma Europe B.V.

Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder (SYNERGY)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

United States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
Medical University of Vienna

Recruiting

Targeting Microbiota in Female Overactive Bladder Syndrome

Urinary Bladder, Overactive | Microbiota

Austria
Rinicare Ltd
Manchester University NHS Foundation Trust

Not yet recruiting

Controlled Trial to Demonstrate a Reduction in the Number of Oliguria Events in Patients Being Managed in a Critical Care Unit, Following Cardiac Surgery, When a Novel Oliguria Prediction Tool (STABILITY UO) is Used to Identify Patients at Risk, Compared to Standard of Care.

Acute Kidney Injury

United Kingdom
FemPulse Corporation

Completed

Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device

Urinary Bladder, Overactive

United States
Hospital General Universitario Gregorio Marañon

Unknown

Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01) (PROERCAN01)

Renal Insufficiency, Chronic | Proteinuria

Spain
Boehringer Ingelheim

Completed

TELMA - Observational Study in Daily Medical Practice of the Effectiveness of Telmisartan for Treatment of Hypertension in Patients With and Without Confirmed Albuminuria in Belgium

Hypertension

Belgium
Ankara Yildirim Beyazıt University

Not yet recruiting

Comparison of the Effects of Transcutaneous Electrical Nerve Stimulation Protocols in Women With Overactive Bladder

Overactive Bladder
Ataturk Training and Research Hospital

Not yet recruiting

The Effects of Pelvic Floor Muscle Training in Women With Overactive Bladdder

Overactive Bladder
University of Pennsylvania
Pfizer

Completed

Fall Prevention in Older Adults With OAB

Overactive Bladder
Pamukkale University

Completed

Intravaginal Electrical Stimulation With Different Treatment Frequency in Women With Idiopathic Overactive Bladder

Overactive Bladder

Turkey
Far Eastern Memorial Hospital

Completed

Efficacy of Biofeedback PFMT and Medication in Women With Overactive Bladder (PFMT)

Overactive Bladder

Taiwan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
Pamukkale University

Completed

ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients

Overactive Bladder

Turkey
Bayer

Completed

Study to Gather Information About the Actual Use of an Adhesive Patch Placed on the Skin to Deliver Oxytrol Through the Skin Into the Bloodstream.

Overactive Bladder

United States
Medy-Tox

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of MEDITOXIN® in Subject With Idiopathic Overactive Bladder

Overactive Bladder

Korea, Republic of
Samsung Medical Center
Pfizer

Completed

Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder

Overactive Bladder

Korea, Republic of
Frank Tu
Berlex Foundation

Terminated

Local Anesthetic Treatments for Overactive Bladder

Overactive Bladder

United States
Dong-A ST Co., Ltd.

Completed

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

Overactive Bladder

Korea, Republic of
Ipsen

Terminated

Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder

Overactive Bladder

United Kingdom, Spain, Netherlands, Belgium, France, Germany, Czechia, Italy
University Hospital Plymouth NHS Trust

Completed

Does Bladder Training Improve the Efficacy of Nerve Stimulation in Women With Refractory Overactive Bladders

Overactive Bladder

United Kingdom
Stéphane Bolduc
Pfizer

Completed

Extension Study of Fesoterodine for Overactive Bladder Syndrome in Children. (FOXY2015)

Overactive Bladder

Canada
University of Alabama at Birmingham

Terminated

Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder (HydrA)

Overactive Bladder

United States
Seyda TOPRAK CELENAY

Unknown

Effects of Connective Tissue Massage in Women With Overactive Bladder

Overactive Bladder

Turkey
Ankara Training and Research Hospital
Ministry of Health, Turkey

Completed

Behavioural Therapy With Checklist for Overactive Bladder

Overactive Bladder

Turkey
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy and Safety of the Mirabegron Compared With Solifenacin in Treatment of Overactive Bladder

Overactive Bladder

Bangladesh
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients

Overactive Bladder

Japan
University of New Mexico

Completed

Hypnotherapy for Treatment of Overactive Bladder

Overactive Bladder
The Cleveland Clinic
Pfizer

Unknown

Premarin Versus Toviaz for Treatment of Overactive Bladder

Overactive Bladder

United States
Alexandria University

Completed

Transcutaneous Posterior Tibial Nerve Electrostimulation With Low Dose Trospium Chloride in OAB in Females

Overactive Bladder
Duramed Research

Completed

A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder

Overactive Bladder

United States, Canada
Dong-A ST Co., Ltd.

Unknown

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects

Overactive Bladder
Meir Medical Center

Withdrawn

Efficacy of Transcutaneous Nerve Stimulation on Improvement of Overactive Bladder Symptoms (TENSOAB)

Overactive Bladder

Israel
Children's Hospital Zagreb
University Hospital for Infectious Diseases, Croatia

Unknown

Urinary Biomarkers in Overactive Bladder in Children

Overactive Bladder

Croatia
IWK Health Centre

Terminated

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

Overactive Bladder

Canada
Asan Medical Center
Astellas Pharma Korea, Inc.

Completed

Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency

Overactive Bladder | Urinary Bladder, Overactive

Korea, Republic of
Astellas Pharma Inc

Completed

Reproducibility Study of OABSS and Its Response to Treatment (RESORT part 2)

Overactive Bladder

Thailand
Karolinska Institutet

Completed

Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists

Overactive Bladder

Sweden
Allergan

Terminated

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder

Overactive Bladder

Serbia, Turkey, Greece, Egypt, Lebanon, India
Guang'anmen Hospital of China Academy of Chinese...
Beijing Hospital; Capital Medical University

Unknown

Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study

Overactive Bladder

China
Bayer

Completed

FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period (FREEDOM)

Overactive Bladder

South Africa
Pfizer

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Overactive Bladder

Denmark, United States, Canada, Costa Rica, Belgium, Czech Republic, Colombia, Germany, Hungary, Korea, Republic of, Spain, Chile, Taiwan, India, Brazil, Singapore, Greece, Hong Kong, Italy, Sweden, Poland, South Africa, Malaysia, Rom... and more
Washington University School of Medicine

Completed

Comparative Urine Proteomic Studies of Overactive Bladder in Humans

Overactive Bladder

United States
Seoul National University Hospital

Unknown

MIrabegron With oveRACtive bLadder Symptoms in mEn

Overactive Bladder

Korea, Republic of
Soonchunhyang University Hospital

Completed

The Efficacy of Solifenacin With or Without Tamsulosin in Adult Women With Overactive Bladder (OAB)

Overactive Bladder

Korea, Republic of
Loma Linda University

Withdrawn

Neuromodulation Implantation Settings Variation for Overactive Bladder

Overactive Bladder

United States
Astellas Pharma Inc

Completed

Post Marketing Survey of Vesicare in Japan (SET-Q)

Overactive Bladder

Japan
Bay State Clinical Trials, Inc.

Terminated

Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder

Overactive Bladder

United States

3

Subscribe